Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $7.11 on 1/5/24 after a major increase of 12.5%. Moreover, unusually high trading volume at 193% of normal accompanied the advance. The stock has risen 13.4% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, LFCR is expected to be a major Value Eraser.
Lifecore Biomedical is currently unrated.
Rating Review
The stock is currently unrated.